Ethical Thinking on Subjects' Rights and Interests Protection in Psychiatric Drug Clinical Trials
10.12026/j.issn.1001-8565.2017.08.17
- VernacularTitle:精神类药物临床试验中受试者权益保障的伦理思考
- Author:
Yunjia LIAO
;
Jinxian GU
- Keywords:
Psychiatric Drug;
Clinical Trial;
Subjects;
Rights and Interests Protection
- From:
Chinese Medical Ethics
2017;30(8):994-997
- CountryChina
- Language:Chinese
-
Abstract:
Due to the special nature of mental patients and psychiatric drugs,we have to recruit mental patients as subjects in psychiatric drug clinical trials.In the process of the experiments,there exist ethical problems.For example,the right of life and health is threatened,the informed consent is insufficient,and the privacy of the subjects cannot be protected.This paper ethically analyzed them,explored the ethical principles,and proposed some objective and feasible countermeasures,in order to promote the development of medicine and health care and protect the rights of mental patients in psychotropic drug clinical trials.
